Back to MW MARSHALL WACE, LLP

CRDFCRDF
Showing 6 of 12 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CARDIFF ONCOLOGY INC

MARSHALL WACE, LLP holds 162,214 shares of CRDF (CARDIFF ONCOLOGY INC), worth $210,879 as of 2026-Q2. This is a new position. CRDF represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$210,879

Current Shares

162,214

Total Value Change

-$171,001

Total Shares Change

+19,188

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
162,214
-
$210,8790.0%$1.30
32
2025-Q3
Exited
0
-100.0%
$00.0%$2.08
0
2025-Q2
Decreased
298,715
-26.1%
$940,9530.0%$3.15
0
2025-Q1
Increased
404,310
+545.9%
$1.3M0.0%$3.29
41
2024-Q4
Decreased
62,600
-56.2%
$271,6830.0%$4.26
0
2024-Q3
Decreased
143,026
-52.1%
$381,8800.0%$2.77
0

Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used